Comparison of reactogenicity and antigenicity of M37 rotavirus vaccine and rhesus-rotavirus-based quadrivalent vaccine.

@article{Flores1990ComparisonOR,
  title={Comparison of reactogenicity and antigenicity of M37 rotavirus vaccine and rhesus-rotavirus-based quadrivalent vaccine.},
  author={Jorge Flores and Irene P{\'e}rez-Schael and M Victoria Blanco and Lewis White and Dania Garc{\'i}a and Mateja Vilar and Walter Cunto and Rosabel Gonz{\'a}lez and Christopher Urbina and J Boher},
  journal={Lancet},
  year={1990},
  volume={336 8711},
  pages={330-4}
}
90 Venezuelan infants aged 10-20 weeks were randomly allocated to four groups which received one of the following: the M37 vaccine (1 x 10(4) pfu [plaque-forming units]); quadrivalent rotavirus vaccine (1 x 10(4) pfu each of serotype 3 rhesus rotavirus [RRV] and human rotavirus-RRV reassortants of serotypes 1, 2, and 4); balanced quadrivalent vaccine consisting of 1 x 10(4) pfu of serotype 1 and 3 components but 5 x 10(4) pfu of serotype 2 and 4 components; or placebo. The frequencies of… CONTINUE READING